Over 1650 Total Lots Up For Auction at Five Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12, PA 05/15

Dr. Jessica Donington

Thoracic surgeon named 2018 ASTRO honorary member
October 18, 2018
ASTRO Rad Oncology Radiation Therapy
Dr. Jessica Donington
Jessica Donington, MD, MS, a thoracic surgeon and professor at the University of Chicago, has been selected as the 2018 American Society for Radiation Oncology (ASTRO) Honorary Member. Dr. Donington will receive the highest honor ASTRO awards to distinguished cancer researchers and leaders in disciplines outside of radiation oncology, radiobiology or radiation physics, at an awards ceremony on October 23 during ASTRO’s 60th Annual Meeting in San Antonio.

Dr. Donington has long supported collaborations between thoracic surgeons and radiation oncologists to provide lung cancer patients with the best care. As one of two surgeons on the guideline committee, she was a key contributor to the recent ASTRO clinical practice statement on stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer.

Drew Moghanaki, MD, MPH, a fellow member of the ASTRO lung SBRT guideline task force, said Dr. Donington is “a true inter-disciplinary collaborator. She encouraged us to consider all potential benefits that SBRT might have over surgery. We never lost focus on the challenges of shared decision-making for patients who are normally offered surgery as the standard of care.”
stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats
Gregory Videtic, MD, who chairs the ASTRO guidelines committee and nominated Dr. Donington for the award, also noted her commitment for integrated cancer care, describing her as “a very effective leader who has ensured that all specialties represented are given an equal and effective voice.”

Dr. Donington recently became chief of general thoracic surgery and professor at the University of Chicago. From 2007 until 2018, she was an attending surgeon at New York University Langone Medical Center and associate professor at the NYU School of Medicine. Before joining NYU, Dr. Donington was on the faculty at Stanford University, where she collaborated on one of the earliest studies in the United States evaluating single-fraction SBRT in a phase I trial.

A nationally recognized expert in lung cancer, Dr. Donington has been a member of the NRG/RTOG Thoracic Malignancy committee for many years, serving since 2015 as the thoracic surgery co-chair for NRG/RTOG 0839. She has led or co-authored more than 90 papers and has been appointed to the editorial boards of several thoracic oncology journals and scientific advisory boards of multiple lung cancer foundations.

Dr. Donington is the co-chair of the 2019 Multidisciplinary Thoracic Cancers Symposium co-sponsored by ASTRO, the American Society of Clinical Oncology and the Society of Thoracic Surgeons, and was as a member of the steering committee for the 2017 symposium.

You Must Be Logged In To Post A Comment

 

Rad Oncology Homepage

Will you be attending this year's National Proton Conference?
Q&A with Jennifer Maggiore, the National Association for Proton Therapy’s (NAPT) executive director
Varian and Embolx to jointly market embolization microcatheter in US
Expanding interventional oncology portfolio with a focus on liver-directed therapies
FDA clears Novartis’ Pluvicto for earlier use in PSMA-positive prostate cancer
Approved for patients who received one androgen receptor pathway inhibitor (ARPI) but not chemotherapy
World Theranostics Day: The dawn of precision cancer care
Insights from Dr. Ilya Gipp, oncology chief medical officer at GE HealthCare
Eckert & Ziegler to supply lu-177 to AtomVie under new global agreement
Increasingly used in targeted radiopharmaceutical therapies for various cancers
Congress reintroduces ROCR Act to reform Medicare payments for radiation therapy
Seeks to replace per-treatment reimbursement model with episode-based system
More than 16,000 more linear accelerators needed to meet global demand by 2045: study
Researchers highlight urgent need for investment in global radiotherapy infrastructure
RefleXion expands SCINTIX radiotherapy with first freestanding cancer center install
X1 platform provides biology-guided treatment in real time
University Hospitals to build $39 million regional cancer hub at UH TriPoint in Ohio
Follows similar expansions at UH Avon and UH Minoff health centers
The Case FOR radiologic detection & diagnosis versus blood, urine and hormone testing.
ProstatID: A Smarter, Non-Invasive Approach to Prostate Cancer Detection